Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RIVA-ISAVUCONAZOLE DIN 02571692

Status: Approved
Holder: LABORATOIRE RIVA INC.
Molecule: ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)

Health Canada record

Active ingredient(s)ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) 100 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ02AC05 ISAVUCONAZOLE
Original market date
Current status date18-Sep-2026
SourceHealth Canada DPD

Establishment licence of the holder

Laboratoire Riva Inc. — licence 100179, currently licensed, last inspection rating C (2026-01-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)

DINProductCompanyFormStrengthStatus
02483971CRESEMBAAVIR PHARMA INC.CapsuleISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) 100 MGMarketed
02483998CRESEMBAAVIR PHARMA INC.Powder For SolutionISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) 200 MGMarketed
02553279CRESEMBAAVIR PHARMA INC.CapsuleISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) 40 MGMarketed
02571684RIVA-ISAVUCONAZOLELABORATOIRE RIVA INC.CapsuleISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) 40 MGApproved
02571706RIVA-ISAVUCONAZOLELABORATOIRE RIVA INC.Powder For SolutionISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) 200 MGApproved

Notices of Compliance

NOCDateSubmissionReason
383072026-09-18New Drug Submission (NDS)Administrative: Licensing Agreement between two manufacturers
Request a quote for RIVA-ISAVUCONAZOLE

How to read a Canadian DIN record